Eqis Capital Management, Inc. Edwards Lifesciences Corp Transaction History

Eqis Capital Management, Inc.

$1.21 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $157,473 - $212,252	2,273 Added 77.98%	5,188 $359,000
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $237,310 - $274,971	2,915 New	2,915 $274,000
Q3 2022 Oct 24, 2022	SELL	$82.37 - $107.29 $21,828 - $28,431	-265 Reduced 9.6%	2,494 $206,000
Q2 2022 Aug 08, 2022	SELL	$86.5 - $128.27 $37,195 - $55,156	-430 Reduced 13.48%	2,759 $262,000
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $103,795 - $130,650	-1,018 Reduced 24.2%	3,189 $375,000
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $50,100 - $61,550	471 Added 12.61%	4,207 $545,000
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $842,318 - $1 Million	-8,185 Reduced 68.66%	3,736 $423,000
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $12,827 - $16,028	-153 Reduced 1.27%	11,921 $1.24 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $37,373 - $43,068	-475 Reduced 3.79%	12,074 $1.01 Million
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $10,036 - $12,772	-140 Reduced 1.1%	12,549 $1.15 Million
Q3 2020 Nov 10, 2020	BUY	$67.19 - $87.44 $28,824 - $37,511	429 Added 3.5%	12,689 $1.01 Million
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $365,091 - $488,247	6,345 Added 107.27%	12,260 $847,000
Q1 2020 May 12, 2020	SELL	$52.41 - $81.0 $70,648 - $109,188	-1,348 Reduced 18.56%	5,915 $1.38 Million
Q4 2019 Jan 24, 2020	SELL	$71.7 - $82.09 $64,243 - $73,552	-896 Reduced 10.98%	7,263 $1.69 Million
Q3 2019 Nov 05, 2019	BUY	$61.55 - $75.43 $21,665 - $26,551	352 Added 4.51%	8,159 $1.79 Million
Q2 2019 Jul 18, 2019	SELL	$55.74 - $64.41 $76,586 - $88,499	-1,374 Reduced 14.97%	7,807 $1.44 Million
Q1 2019 Apr 18, 2019	SELL	$47.89 - $64.05 $304,388 - $407,101	-6,356 Reduced 40.91%	9,181 $1.76 Million
Q4 2018 Jan 25, 2019	BUY	$46.41 - $56.94 $87,668 - $107,559	1,889 Added 13.84%	15,537 $2.38 Million
Q3 2018 Oct 17, 2018	BUY	$45.7 - $58.03 $8,911 - $11,315	195 Added 1.45%	13,648 $1.94 Million
Q2 2018 Jul 27, 2018	SELL	$42.45 - $51.3 $571,971 - $691,216	-13,474 Reduced 50.04%	13,453 $1.96 Million
Q1 2018 Apr 06, 2018	SELL	$37.19 - $47.45 $117,222 - $149,562	-3,152 Reduced 10.48%	26,927 $3.76 Million
Q4 2017 Jan 25, 2018	BUY	$33.79 - $39.39 $1.02 Million - $1.18 Million	30,079	30,079 $3.39 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account